Featured Articles
Chiron's Proleukin Granted a Market...
EMERYVILLE, Calif.--(BW HealthWire)--Jan. 8, 1999--Chiron Corp. (Nasdaq:CHIR) announced today that the Canadian Healt...
Drug for preemies linked to problem...
Treating premature infants with a common steroid can prevent chronic lung disease, but possibly at a cost, a new stud...
Characterization of the Gating Conf...
INTRODUCTIONIt has been found that N-methyl-u-uspartale (NMDA) channel antagonists possess a broad-spectrum anliepilep...
Positive Clinical Data Reported for...
FOSTER CITY, Calif.--(BUSINESS WIRE)--May 2, 1996--At the Society for Investigative Dermatology (SID) Conference held th...
Apotex Receives Final Approval for ...
WESTON, Fla. -- Apotex Corp. today announced that it has received final approval from the U.S. Food and Drug Administ...